Eurofins Viracor (formerly IBT, founded in 1983) was among the first commercial labs to offer specialized allergy and immunology testing options not previously available such as Latex Sensitivity IVD, chronic urticarial (CU Index) testing and molecular component testing for Alpha-Gal, peanut, soy, egg and milk.
Viracor uses ImmunoCAP® and allergen-specific IgE enzyme immunoassays as the primary testing modes for your allergy diagnosis. These methods are intended for in vitro diagnostic use as an aid in the clinical diagnosis of antibody-mediated allergic disorders in conjunction with other clinical findings.
Molecular components are a great way to take allergy diagnosis to the next level by diving into allergy severity as well as potential cross-reactivity.
As you know, 90% of food allergies are caused by milk, eggs, peanuts, tree nuts, fish, shellfish, soy and wheat. Knowing which components your patients might be allergic to is critical to their individual allergen treatment and management. Get the facts with Viracor's molecular component testing, most with results reported in one to two days from specimen receipt.
In patients with a history of adverse drug reactions and for whom skin testing or in vitro specific IgE testing is not available or appropriate, consider the benefits of BasoFunction HRT testing. The Basophil Activation Test assesses the ability of the patient’s basophils to release histamine when activated by a non-specific stimulus, formyl-methionyl-leucyl-phenylalanine (fMLP). The BasoFunction test measures histamine released in vitro following challenge with the suspected allergen. Evaluate over 60 BasoFunction targets: